1. JenkinsonHF, LamontRJ (2005) Oral microbial communities in sickness and in health. Trends Microbiol 13: 589–595.
2. PattonLL, PhelanJA, Ramos-GomezFJ, NittayanantaW, ShiboskiCH, et al. (2002) Prevalence and classification of HIV-associated oral lesions. Oral Dis 8: 98–109.
3. ChattopadhyayA, CaplanDJ, SladeGD, ShugarsDC, TienHC, et al. (2005) Risk indicators for oral candidiasis and oral hairy leukoplakia in HIV-infected adults. Community Dent Oral Epidemiol 33: 35–44.
4. Koletar SL, Smurzynski M, Wu K, Collier AC, Bosch RJ, et al.. AIDS-defining illnesses occurring in treatment-experienced HIV-1-infected persons followed in the ACTG Longitudinal Linked Randomized Trials (ALLRT) study [Abstract 1017]. In Proceedings of the 15th Conference on Retroviruses & Opportunistic Infections; February 3–6, 2008; Boston, MA. Available: http://retroconference.org/. Accessed 2/3/13.
5. ThompsonGR3rd, PatelPK, KirkpatrickWR, WestbrookSD, BergD, et al. (2010) Oropharyngeal candidiasis in the era of antiretroviral therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 109: 488–495.
6. PatelPK, ErlandsenJE, KirkpatrickWR, BergDK, WestbrookSD, et al. (2012) The Changing Epidemiology of Oropharyngeal Candidiasis in Patients with HIV/AIDS in the Era of Antiretroviral Therapy. AIDS Res Treat 2012: 262471.
7. KinrossJM, DarziAW, NicholsonJK (2011) Gut microbiome-host interactions in health and disease. Genome Med 3: 14.
8. NelsonKE, WeinstockGM, HighlanderSK, WorleyKC, CreasyHH, et al. (2010) A catalog of reference genomes from the human microbiome. Science 328: 994–999.
9. GriceEA, KongHH, ConlanS, DemingCB, DavisJ, et al. (2009) Topographical and temporal diversity of the human skin microbiome. Science 324: 1190–1192.
10. HuseSM, YeY, ZhouY, FodorAA (2012) A Core Human Microbiome as Viewed through 16S rRNA Sequence Clusters. PLoS ONE 7: e34242.
11. ClementeJC, UrsellLK, ParfreyLW, KnightR (2012) The Impact of the Gut Microbiota on Human Health: An Integrative View. Cell 148: 1258–1270.
12. AasJA, BarbutoSM, AlpagotT, OlsenI, DewhirstFE, et al. (2007) Subgingival plaque microbiota in HIV positive patients. Journal of Clinical Periodontology 34: 189–195.
13. IlievID, FunariVA, TaylorKD, NguyenQ, ReyesCN, et al. (2012) Interactions Between Commensal Fungi and the C-Type Lectin Receptor Dectin-1 Influence Colitis. Science 336: 1314–1317.
14. GhannoumMA, JurevicRJ, MukherjeePK, CuiF, SikaroodiM, et al. (2010) Characterization of the Oral Fungal Microbiome (Mycobiome) in Healthy Individuals. PLoS Pathogens 6: e1000713.
15. PelegAY, HoganDA, MylonakisE (2010) Medically important bacterial-fungal interactions. Nat Rev Microbiol 8: 340–349.
16. LandlingerC, BaskovaL, PreunerS, WillingerB, BuchtaV, et al. (2008) Identification of fungal species by fragment length analysis of the internally transcribed spacer 2 region. Eur J Clin Microbiol Infect Dis 28 (6) 613–22.
17. BormanAM, LintonCJ, MilesSJ, JohnsonEM (2008) Molecular identification of pathogenic fungi. Journal of Antimicrobial Chemotherapy 61: i7–12.
18. GillevetP, SikaroodiM, KeshavarzianA, MutluEA (2010) Quantitative assessment of the human gut microbiome using multitag pyrosequencing. Chem Biodivers 7: 1065–1075.
19. ChakravortyS, HelbD, BurdayM, ConnellN, AllandD (2007) A detailed analysis of 16S ribosomal RNA gene segments for the diagnosis of pathogenic bacteria. Journal of Microbiological Methods 69: 330–339.
20. SpearGT, SikaroodiM, ZariffardMR, LandayAL, FrenchAL, et al. (2008) Comparison of the diversity of the vaginal microbiota in HIV-infected and HIV-uninfected women with or without bacterial vaginosis. J Infect Dis 198: 1131–1140.
21. Gillevet PM, inventor; BioSpherex LLC, assignee (2013 December 10) Multitag Sequencing and Ecogenomic Analysis. United States Patent 8,603,749.
22. RomanelliAM, SuttonDA, ThompsonEH, RinaldiMG, WickesBL (2010) Sequence-based identification of filamentous basidiomycetous fungi from clinical specimens: a cautionary note. J Clin Microbiol 48: 741–752.
23. CormackBP, BertramG, EgertonM, GowNA, FalkowS, et al. (1997) Yeast-enhanced green fluorescent protein (yEGFP) a reporter of gene expression in Candida albicans. Microbiology 143: 303–311.
24. SwindellK, LattifAA, ChandraJ, MukherjeePK, GhannoumMA (2009) Parenteral Lipid Emulsion Induces Germination of Candida albicans and Increases Biofilm Formation on Medical Catheter Surfaces. J Infect Dis 200: 473–480.
25. KuhnDM, MukherjeePK, ClarkeTA, PujolC, ChandraJ, et al. (2004) Candida parapsilosis characterization in an outbreak setting. Emerging Infectious Diseases 10: 1074–1081.
26. ChandraJ, MukherjeePK, GhannoumMA (2008) In vitro growth and analysis of Candida biofilms. Nature Protocols 3: 1909–1924.
27. ChandraJ, KuhnDM, MukherjeePK, HoyerLL, McCormickT, et al. (2001) Biofilm formation by the fungal pathogen Candida albicans - development, architecture and drug resistance. Journal of Bacteriology 183: 5385–5394.
28. ChandraJ, MukherjeePK, LeidichSD, FaddoulFF, HoyerLL, et al. (2001) Antifungal resistance of candidal biofilms formed on denture acrylic in vitro. Journal of Dental Research 80: 903–908.
29. PienaarED, YoungT, HolmesH (2010) Interventions for the prevention and management of oropharyngeal candidiasis associated with HIV infection in adults and children. Cochrane Database of Systematic Reviews 11: CD003940.
30. HiseAG, TomalkaJ, GanesanS, PatelK, HallBA, et al. (2009) An essential role for the NLRP3 inflammasome in host defense against the human fungal pathogen Candida albicans. Cell Host Microbe 5: 487–497.
31. TangN, LiuL, KangK, MukherjeePK, TakaharaM, et al. (2004) Inhibition of monocytic interleukin-12 production by Candida albicans via selective activation of ERK mitogen-activated protein kinase. Infection and Immunity 72: 2513–2520.
32. GhannoumMA, MukherjeePK, JurevicRJ, RetuertoM, BrownRE, et al. (2011) Metabolomics Reveals Differential Levels of Oral Metabolites in HIV-Infected Patients: Toward Novel Diagnostic Targets. Omics 17: 5–15.
33. CaporasoJG, KuczynskiJ, StombaughJ, BittingerK, BushmanFD, et al. (2010) QIIME allows analysis of high-throughput community sequencing data. Nat Methods 7: 335–336.
34. R Core Team (2013) R: A language and environment for statistical computing. Available http://www.R-project.org. Accessed 2 February 2013.
35. Revelle W (2013) psych: procedures for personality and psychological research. Available http://CRAN.R-project.org/package=psych Version = 1.3.10. Accessed 20 December 2013.
36. NoktaM (2008) Oral manifestations associated with HIV infection. Curr HIV/AIDS Rep 5: 5–12.
37. SchislerD, KurtzmanC, BothastR, SliningerP (1995) Evaluation of yeasts for biological control of Fusarium dry rot of potatoes. American Potato Journal 72: 339–353.
38. StarmerWT, GanterPF, PhaffHJ (1986) Quantum and continuous evolution of DNA base composition in the yeast genus Pichia. Evolution 40: 1263–1274.
39. Golubev W (2006) Antagonistic interactions among yeasts. Biodiversity and Ecophysiology of Yeasts: Springer. pp. 197–219.
40. AntunesJ, AguiarC (2012) Search for killer phenotypes with potential for biological control. Annals of microbiology 62: 427–433.
41. DruveforsUA, SchnurerJ (2005) Mold-inhibitory activity of different yeast species during airtight storage of wheat grain. FEMS Yeast Res 5: 373–378.
42. JungPP, FriedrichA, SoucietJL, LouisV, PotierS, et al. (2010) Complete mitochondrial genome sequence of the yeast Pichia farinosa and comparative analysis of closely related species. Curr Genet 56: 507–515.
43. WalkerGM (2010) Pichia anomala: cell physiology and biotechnology relative to other yeasts. Antonie Van Leeuwenhoek 99 (1) 25–34.
44. EladY (2003) Biocontrol of foliar pathogens: mechanisms and application. Commun Agric Appl Biol Sci 68: 17–24.
45. CaoS, YuanY, HuZ, ZhengY (2010) Combination of Pichia membranifaciens and ammonium molybdate for controlling blue mould caused by Penicillium expansum in peach fruit. Int J Food Microbiol 141: 173–176.
46. SantosA, San MauroM, BravoE, MarquinaD (2009) PMKT2, a new killer toxin from Pichia membranifaciens, and its promising biotechnological properties for control of the spoilage yeast Brettanomyces bruxellensis. Microbiology 155: 624–634.
47. OlstorpeM, PassothV (2010) Pichia anomala in grain biopreservation. Antonie Van Leeuwenhoek 99 (1) 57–62.
48. KaganBL (1983) Mode of action of yeast killer toxins: channel formation in lipid bilayer membranes. Nature 302: 709–711.
49. İzgüF, AltınbayD, AcunT (2006) Killer toxin of Pichia anomala NCYC 432; purification, characterization and its exo-β-1,3-glucanase activity. Enzyme and Microbial Technology 39: 669–676.
50. CaoS, ZhengY, TangS, WangK (2008) Improved control of anthracnose rot in loquat fruit by a combination treatment of Pichia membranifaciens with CaCl(2). Int J Food Microbiol 126: 216–220.
51. DruveforsUA, PassothV, SchnurerJ (2005) Nutrient effects on biocontrol of Penicillium roqueforti by Pichia anomala J121 during airtight storage of wheat. Appl Environ Microbiol 71: 1865–1869.
52. XuXB, TianSP (2008) Reducing oxidative stress in sweet cherry fruit by Pichia membranaefaciens: a possible mode of action against Penicillium expansum. J Appl Microbiol 105: 1170–1177.
53. ZhaoJ, MouY, ShanT, LiY, ZhouL, et al. (2010) Antimicrobial metabolites from the endophytic fungus Pichia guilliermondii isolated from Paris polyphylla var. yunnanensis. Molecules 15: 7961–7970.
54. JijakliMH, LepoivreP (1998) Characterization of an Exo-beta-1,3-Glucanase Produced by Pichia anomala Strain K, Antagonist of Botrytis cinerea on Apples. Phytopathology 88: 335–343.
55. DrobyS, HofsteinR, WilsonCL, WisniewskiM, FridlenderB, et al. (1993) Pilot Testing of Pichia guilliermondii: A Biocontrol Agent of Postharvest Diseases of Citrus Fruit. Biological Control 3: 47–52.
56. DrobyS, WisniewskiME, CohenL, WeissB, TouitouD, et al. (1997) Influence of CaCl(2) on Penicillium digitatum, Grapefruit Peel Tissue, and Biocontrol Activity of Pichia guilliermondii. Phytopathology 87: 310–315.
57. GiobbeS, MarcedduS, SchermB, ZaraG, MazzarelloVL, et al. (2007) The strange case of a biofilm-forming strain of Pichia fermentans, which controls Monilinia brown rot on apple but is pathogenic on peach fruit. FEMS Yeast Res 7: 1389–1398.
58. KumamotoCA, VincesMD (2005) Alternative Candida albicans lifestyles: Growth on Surfaces. Annual Review of Microbiology 59: 113–133.
59. ChandraJ, MukherjeePK, GhannoumMA (2011) Candida Biofilms Associated with CVC and Medical Devices. Mycoses 55: 46–57.
60. ChandraJ, MukherjeePK, GhannoumMA (2010) Fungal Biofilms in the Clinical Lab Setting. Current Reports in Fungal Infection 4: 137–144.
61. ConlanS, KongHH, SegreJA (2012) Species-level analysis of DNA sequence data from the NIH Human Microbiome Project. PLoS One 7: e47075.
62. LiK, BihanM, YoosephS, MetheBA (2012) Analyses of the microbial diversity across the human microbiome. PLoS One 7: e32118.
63. ZarcoMF, VessTJ, GinsburgGS (2012) The oral microbiome in health and disease and the potential impact on personalized dental medicine. Oral Dis 18: 109–120.
64. ZauraE, KeijserBJ, HuseSM, CrielaardW (2009) Defining the healthy “core microbiome” of oral microbial communities. BMC Microbiol 9: 259.
65. HoganDA, KolterR (2002) Pseudomonas - Candida interactions: an ecological role for virulence factors. Science 296: 2229–2232.
66. AzoulayE, TimsitJ-F, TaffletM, de LassenceA, DarmonM, et al. (2006) Candida Colonization of the Respiratory Tract and Subsequent Pseudomonas Ventilator-Associated Pneumonia. Chest 129: 110–117.
67. NseirS, JozefowiczE, CavestriB, SendidB, Di PompeoC, et al. (2007) Impact of antifungal treatment on Candida-Pseudomonas interaction: a preliminary retrospective case-control study. Intensive Care Med 33: 137–142.
68. DyessDL, GarrisonRN, FryDE (1985) Candida sepsis. Implications of polymicrobial blood-borne infection. ArchSurg 120: 345–348.
69. NavazeshM, MulliganR, PogodaJ, GreenspanD, AlvesM, et al. (2005) The effect of HAART on salivary microbiota in the Women's Interagency HIV Study (WIHS). Oral Surg Oral Med Oral Pathol Oral Radiol Endod 100: 701–708.
70. WorkmanSN, BeenFE, CrawfordSR, LavoieMC (2008) Bacteriocin-like inhibitory substances from Campylobacter spp. Antonie Van Leeuwenhoek 93: 435–436.
71. DupontPF (1995) Candida albicans, the opportunist. A cellular and molecular perspective. JAmPodiatrMedAssoc 85: 104–115.
72. MartinMV, CraigGT, LambDJ (1984) An investigation of the role of true hypha production in the pathogenesis of experimental oral candidosis. Sabouraudia 22: 471–476.
73. CannonRD, HolmesAR, MasonAB, MonkBC (1995) Oral Candida: clearance, colonization, or candidiasis? JDentRes 74: 1152–1161.
74. SamaranayakeYH, WuPC, SamaranayakeLP, SoM, YuenKY (1994) Adhesion and colonisation of Candida krusei on host surfaces. JMedMicrobiol 41: 250–258.
75. De BernardisF, BoccaneraM, RainaldiL, GuerraCE, QuintiI, et al. (1992) The secretion of aspartyl proteinase, a virulence enzyme, by isolates of Candida albicans from the oral cavity of HIV-infected subjects. EurJEpidemiol 8: 362–367.
76. SardiJC, DuqueC, HoflingJF, GoncalvesRB (2012) Genetic and phenotypic evaluation of Candida albicans strains isolated from subgingival biofilm of diabetic patients with chronic periodontitis. Med Mycol 50: 467–475.
77. GhannoumMA, Abu-ElteenKH (1990) Pathogenicity determinants of Candida. Mycoses 33: 265–282.
78. GhannoumMA (2000) Potential role of phospholipases in virulence and fungal pathogenesis. Clinical Microbiology Reviews 13: 122–143.
79. RichardsonMD, SmithH (1981) Production of germ tubes by virulent and attenuated strains of Candida albicans. J Infect Dis 144: 565–569.
80. RestucciaC, GiusinoF, LicciardelloF, RandazzoC, CaggiaC, et al. (2006) Biological control of peach fungal pathogens by commercial products and indigenous yeasts. J Food Prot 69: 2465–2470.
81. SantosA, MarquinaD (2004) Ion channel activity by Pichia membranifaciens killer toxin. Yeast 21: 151–162.
82. FredlundE, BrobergA, BoysenME, KenneL, SchnurerJ (2004) Metabolite profiles of the biocontrol yeast Pichia anomala J121 grown under oxygen limitation. Appl Microbiol Biotechnol 64: 403–409.